Publications by authors named "Nalin Subasinghe"

Claim this Profile
D
Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Ca 2.2) blockers for the treatment of pain.
Mark J Wall, Nalin L Subasinghe, Michael P Winters, Mary Lou Lubin, Michael F A Finley

Bioorg Med Chem Lett· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and SAR of novel tetrahydropyrrolo[3,4-c]pyrazoles as inhibitors of the N-type calcium channel.
Michael P Winters, Nalin Subasinghe, Mark Wall, Edward Beck, Michael R Brandt

Bioorg Med Chem Lett· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and SAR of a novel series of 2,4,5,6-tetrahydrocyclopenta[c]pyrazoles as N-type calcium channel inhibitors.
Michael P Winters, Nalin Subasinghe, Mark Wall, Edward Beck, Michael R Brandt

Bioorg Med Chem Lett· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel series of N-(azetidin-3-yl)-2-(heteroarylamino)acetamide CCR2 antagonists.
Nalin L Subasinghe, James Lanter, Thomas Markotan, Evan Opas, Sandra McKenney

Bioorg Med Chem Lett· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of polyethylene glycol-modified biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s.
Nalin L Subasinghe, Ehab Khalil, Jeremy M Travins, Farah Ali, Shelley K Ballentine

Bioorg Med Chem Lett· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel series of pyrazolylpiperidine N-type calcium channel blockers.
Nalin L Subasinghe, Mark J Wall, Michael P Winters, Ning Qin, Mary Lou Lubin

Bioorg Med Chem Lett· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The discovery of novel cyclohexylamide CCR2 antagonists.
James C Lanter, Thomas P Markotan, Xuqing Zhang, Nalin Subasinghe, Fu-An Kang

Bioorg Med Chem Lett· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biphenylsulfonyl-thiophene-carboxamidine inhibitors of the complement component C1s.
Jeremy M Travins, Farah Ali, Hui Huang, Shelley K Ballentine, Ehab Khalil, Nalin L Subasinghe

Bioorg Med Chem Lett· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboxylic acid bioisosteres acylsulfonamides, acylsulfamides, and sulfonylureas as novel antagonists of the CXCR2 receptor.
Michael P Winters, Carl Crysler, Nalin Subasinghe, Declan Ryan, Lynette Leong

Bioorg Med Chem Lett· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1s.
Nalin L Subasinghe, Jeremy M Travins, Farah Ali, Hui Huang, Shelley K Ballentine

Bioorg Med Chem Lett· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel series of potent and selective small molecule inhibitors of the complement component C1s.
Nalin L Subasinghe, Farah Ali, Carl R Illig, M Jonathan Rudolph, Scott Klein

Bioorg Med Chem Lett· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of 4,5-disubstituted-thiophene-2-amidines as potent urokinase inhibitors.
M Jonathan Rudolph, Carl R Illig, Nalin L Subasinghe, Kenneth J Wilson, James B Hoffman

Bioorg Med Chem Lett· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis